Purpose
Survival benefit of radical surgery for locally recurrent rectal cancer depends on whether disease is cured rather than whether death is delayed. Cured patients gain decades of life and are spared from sufferings with recurrence. Unfortunately, the majority of patients undergoing surgery, particularly those with extrarectal pelvic recurrence, have poor outcomes with occult disseminated disease. This study was designed to identify which of these patients are curable.
Methods
Of 61 patients with pelvic recurrence treated by radical reexcision more than nine years before, 36 patients whose initial surgery was abdominoperineal resection were examined retrospectively. We used the logistic regression and Gamel-Boag regression models to estimate curability and identify predictors of cure.
Results
Ten patients survived five years and seven survived ten years. The cumulative disease-specific mortality curve leveled off 6.5 years after reexcision and remained at 74 percent (95 percent confidence interval, 60–89), indicating that the remaining 26 percent are curable. This value is comparable with the 23 percent curability estimated by the Gamel-Boag model, which also found that the disease-free interval from the initial surgery to the first recurrence is the best predictor of cure (P = 0.005). Of 11 patients with disease-free interval three years or more, 6 survived ten years, whereas 8 of 9 patients with disease-free interval less than one year died of second recurrence within three years of reexcision.
Conclusions
Even patients with extrarectal pelvic recurrence may have isolated disease that is amenable to complete eradication. As a biologic marker, the disease-free interval serves to predict curability and may distinguish isolated disease from occult disseminated disease.
Similar content being viewed by others
References
Sterns MW. Diagnosis and management of recurrent pelvic malignancy following combined abdominoperineal resection. Dis Colon Rectum 1980;23:359–61
Garcia-Aguilar J, Cromwell JW, Marra C, et al. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001;44:1743–8
Lopez-Kostner F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001;44:173–8
Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001;88:988–93
Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002;45:585–92
Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237:502–8
Moriya Y, Akasu T, Fujita S, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004;47:2047–54
Bakx R, van Tinteren H, van Lanshot JJ, et al. Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol 2004;30:857–63
Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer: technical consideration and outcomes. Dis Colon Rectum 1999;42:438–48
Maetani S, Onodera H, Nishikawa T, et al. Significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg 1998;85:521–5
Gamel JW, Bonadona G, Valagussa P, et al. Refined measurement of outcome for adjuvant breast carcinoma therapy. Cancer 2003;97:1139–46
Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc [Ser A] 1949;B11:15–44
Gamel JW, McLeen IW. Stable multivariate extension of the log normal survival model. Comput Biomed Res 1994;27:148–55
Maetani S, Nakajima T, Nishikawa T. Parametric mean survival time analysis in gastric cancer patients. Med Decis Making 2004;24:131–41
Maetani S, Nishikawa T, Iijima Y, et al. Extensive en bloc resection of regionally recurrent carcinoma of the rectum. Cancer 1992;69:2876–83
Azevedo JP, Dezois RR, Gunderson LL. Locally recurrent rectal cancer: surgical strategy. Word J Surg 1992;16:490–4
Chmielarz A, Kryj M, Wolch J, Pottorak S, Sacher A, Lasek-Kryj M. Prognostic factors for the time of occurrence and dynamics of distant metastases and local recurrence after radical treatment in patients with rectal cancer. Med Sci Monit 2001;7:1263–9
Dunphy JE. Metastatic and recurrent cancer of the colon and rectum: surgical significance and management. Dis Colon Rectum 1959;2:77–83
Green WW, Blank WA. Perineal recurrence after abdominoperineal resection of carcinoma of the rectum. Dis Colon Rectum 1963;6:125–9
James RD, Johnson RJ, Eddleston B, et al. Prognostic factors in locally recurrent rectal carcinoma treated by radiotherapy. Br J Surg 1983;70:469–72
Wong CS, Cummings BJ, Brierly JD, et al. Treatment of locally recurrent rectal carcinoma: results and prognostic factors. Int J Radiat Oncol Biol Phys 1998;40:427–35
Gagliardi PR, Hawley PR, Hershman MJ, et al. Prognostic factors in surgery for locally recurrent recurrence of rectal cancer. Br J Surg 1995;82:1401–5
Schumpelick V, Braun J. The sacral recurrence of rectal carcinoma. Chirurg 1995;66:931–40
Walz MK, Peitgen K, Meyer-Schwickerath M, et al. Results of surgical treatment of local and locoregional recurrent rectal cancer: an analysis of 54 patients. Zentralbl Chir 1995;120:236–44
Wiggers T, Vries MR, Veeze-Kuypers V. Surgery for local recurrence of rectal carcinoma Dis Colon Rectum 1996;39:323–8
Salo JC, Paty PB, Guillem J, et al. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 1996;6:171–7
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–70
Goldman A. The cure model and time confounded risk in the analysis of survival and other timed events. J Clin Epidemiol 1991;44:1327–40
Gamel JW, Vogel RL. Comparison of parametric and non-parametric survival methods using simulated clinical data. Stat Med 1997;16:1629–43
Nishikawa T, Maetani S. Evaluation of intensive adjuvant chemotherapy in gastric cancer using mean survival compared with log-rank test as a measure of survival benefit. Ann Surg Oncol 2007;14:348–54.
Invited Commentary
Ng’andu NH. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox’s model. Stat Med 1997;16:611–26
Frankel P, Longmate J. Parametric models for accelerated and long-term survival: a comment on proportional hazards. Stat Med 2002;21:3279–89
Farewell VT. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1982;38:1041–6
The Authors Reply
Maetani S, Onodera H, Maruoka Y, Nishikawa T, Tobe T. Prognostic stratification and risk assessment using Akaike information criterion: the case of colorectal cancer. Theor Surg 1989;4:59–66
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Maetani, S., Onodera, H. & Nishikawa, T. Long-Term Cure in Surgery for Extrarectal Pelvic Recurrence of Rectal Cancer. Dis Colon Rectum 50, 1558–1567 (2007). https://doi.org/10.1007/s10350-007-0285-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-007-0285-7